1.Change of Selection to Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang . Gyeongju Primary Care Research Network.
Zu Young YUN ; Dong Wook LEE ; Hee Su JUNG ; Ki Hm PARK ; Sin Hyeong LEE ; Jung Jae PARK ; Dong Ik KIM ; Jae Man KI ; Kyung Rae CHO ; Joon Seok SONG ; Seok CHOI ; Cheang Ho U ; Tae Ho JUNG ; Sook Heong JUNG ; Sung Woo KIM ; Ik KIM
Korean Journal of Family Medicine 2009;30(3):197-201
BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) or Angiotensin II type 1 receptor blockers (ARBs) are compelling indication drugs for hypertensive patients with diabetes mellitus. But prescription rate in 2005 year study of Pohang . Gyeongju area was only 30.8%. Therefore, a study on the change of prescription rate in the same area after 3 years was done. METHODS: During three months from January 2008, 152 hypertensive patients with diabetes mellitus on their prescribed antihypertensive medications by 9 family physicians in visiting order were analyzed. After the analysis, the infl uencing factors for such prescriptions were ascertained by directly visiting each physicians who prescribed them. RESULTS: A regimen of 16 antihypertensive agents were prescribed by these family physicians. Prescription count of ACEIs or ARBs was 101 cases (66.4%). ACEIs single therapy was 19 cases (12.5%), ACEIs combination therapy was 7 cases (4.6%), ARBs single therapy was 31 cases (20.4%) and ARBs combination therapy was 44 cases (28.9%). The ACEIs or ARBs which were selected by physicians that followed "compelling indication" was 5 (55.6%), "excellent reduce pressure effect" was 3 (33.3%) and "public relations of new medicine" was 1 (11.1%). CONCLUSION: In prescribing antihypertensive agents for patients with diabetes mellitus, selection of ACEIs or ARBs was increased from 30.8% to 66.4%. Education of recommended standard by participating in such study and developing of excellent new medicines may increase such change.
Angiotensin II Type 1 Receptor Blockers
;
Angiotensin-Converting Enzyme Inhibitors
;
Antihypertensive Agents
;
Diabetes Mellitus
;
Humans
;
Hypertension
;
Physicians, Family
;
Prescriptions
;
Primary Health Care
2.Selection of Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang-Gyeongju Primary Care Research Network.
Chul Won JANG ; Ki Hoon HA ; Nak Jin SUNG ; Dong Wook LEE ; Kyung Rae CHO ; Sook Heong JUNG ; Seok CHOI ; Jae Man KI ; Sung Woo KIM ; Kyung Ja CHOI ; Dong Ik KIM ; Joon Seok SONG ; Young Kyu CHOI ; Hee Nam SONG ; Ki Heum PARK
Journal of the Korean Academy of Family Medicine 2006;27(9):706-712
BACKGROUND: Angiotensin converting enzyme inhibitor or Angiotensin II type 1 receptor blocker is usually recommended for hypertensive patients with diabetes mellitus. No reports have been made on antihypertensive agents prescribed for these patients in private practice. METHODS: During a one month period of December 2004, 169 hypertensive patients with diabetes mellitus on their prescribed antihypertensive agents by ten family physicians were analyzed. The influencing factors for such prescriptions were analyzed by directly visiting each physicians who prescribed them. RESULTS: A total of 21 antihypertensive agents were prescribed by these family physicians. Single calcium channel blocker therapy was the most common with 55 cases (32.5%), followed by 20 cases (11.8%) of single angiotensin converting enzyme inhibitor therapy and 16 cases of single therapy of Angiotensin II type 1 receptor blocker. The low frequency of prescribing the Angiotensin II type 1 receptor blocker was due to insufficient effect (7), lack of information (5), resistance from the patients from changing the medications (4) and expensive costs (4). CONCLUSION: In prescribing antihypertensive agents for patients with diabetes mellitus, angiotensin converting enzyme inhibitor or Angiotensin II type 1 receptor blocker were chosen less. In order to decrease the incidence of complications in these patients, such agents should be prescribed more.
Antihypertensive Agents*
;
Calcium Channels
;
Diabetes Mellitus*
;
Humans
;
Hypertension
;
Incidence
;
Peptidyl-Dipeptidase A
;
Physicians, Family
;
Prescriptions
;
Primary Health Care*
;
Private Practice
;
Receptor, Angiotensin, Type 1